InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,553.20
(
-0.10%
)
Dow Jones
42,080.37
(
0.00%
)
Brent Oil
76.71
(
-0.83%
)
Bitcoin
62,108.92
(
-0.04%
)
Post# of 253310
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120547
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 243272

Sunday, 07/24/2022 1:02:01 PM

Sunday, July 24, 2022 1:02:01 PM

Post# of 253310

“Despite the market size for B-NHL being at least five times the size of ALL, B-NHL has a smaller pipeline of cell therapies…”

indolent NHL, which comprises a large portion of the NHL market, is an especially tough nut to crack, and this explains, in part, the (relative to ALL) dearth of NHL cell therapies in development.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up